- The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
-
Barber EL, Zsiros E, Lurain JR, Rademaker , Schink JC, Neubauer N
- KMID: 2288533
- J Gynecol Oncol.
- 2013 Jul;24(3):258-264.
- doi: 10.3802/jgo.2013.24.3.258
OBJECTIVE: To determine the efficacy, progression-free survival (PFS) and overall survival (OS) for the combination of intravenous bevacizumab and oral cyclophosphamide in heavily pretreated patients with recurrent ovarian carcinoma. METHODS: A... -
- CITED
-
- Close
- SHARE
-
- Close
